Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing

BACKGROUND: Higher mortality of COVID-19 patients with lung disease is a formidable challenge for the health care system. Genetic association between COVID-19 and various lung disorders must be understood to comprehend the molecular basis of comorbidity and accelerate drug development. METHODS: Lung...

Descripción completa

Detalles Bibliográficos
Autor principal: Das, Asim Bikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447809/
https://www.ncbi.nlm.nih.gov/pubmed/34535131
http://dx.doi.org/10.1186/s12920-021-01079-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447809/
https://www.ncbi.nlm.nih.gov/pubmed/34535131
http://dx.doi.org/10.1186/s12920-021-01079-7

Ejemplares similares